Company News
Assembly Bio Gains 4.9% After Gilead Option
Assembly Bio shares jumped 4.9% after exercising its option to share 40% of U.S. development costs and profits with Gilead.
Assembly Bio can earn up to $280 million in milestones and royalties outside
